Xiu Feng Li
Director/Board Member bij CHANGCHUN BCHT BIOTECHNOLOGY CO.
Vermogen: 260 670 $ op 31-03-2024
Profiel
Xiu Feng Li is plaatsvervangend algemeen directeur bij Changchun High & New Technology Industries (Group), Inc. en zit in de raad van bestuur van 8 andere ondernemingen. De heer Li is afgestudeerd aan de Universiteit van Jilin.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 21-04-2023 | 15 675 ( 0.58% ) | 260 670 $ | 31-03-2024 |
Actieve functies van Xiu Feng Li
| Bedrijven | Functie | Begin |
|---|---|---|
| CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | Corporate Officer/Principal | 26-06-2018 |
| CHANGCHUN BCHT BIOTECHNOLOGY CO. | Director/Board Member | 01-03-2004 |
| Changchun BCHT Pharmaceuticals Co. Ltd. | Director/Board Member | 20-08-2010 |
| Changchun Chenguang Pharmaceutical Co. Ltd. | Director/Board Member | 20-08-2010 |
| Jilin Maifeng Biological Pharmaceutical Co., Ltd. | Director/Board Member | 20-08-2010 |
| Qinhuangdao Shanhaiguan Pharmaceutical Co. Ltd. | Director/Board Member | 20-08-2010 |
Jilin Huakang Pharmaceutical Co. Ltd.
 Jilin Huakang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High & New Technology Industries (Group), Inc., Jilin Huakang Pharmaceutical Co. Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Dunhua, China. | Director/Board Member | 12-03-2014 |
GeneScience Pharmaceuticals Co., Ltd.
 GeneScience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology GeneScience Pharmaceuticals Co., Ltd. engages in the production and sale of biopharmaceutical products. Its products include bioengineering products such as recombinant human growth hormones, active pharmaceutical ingredients such as tripplein acetate and alprostadil, freeze-dried powder injections, small volume injections, biological product intermediates, and medical devices. The company was founded by Lei Jin in 1996 and is headquartered in Changchun, China. | Director/Board Member | 18-03-2014 |
Changchun Baiyi Pharmaceutical Co., Ltd.
 Changchun Baiyi Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Baiyi Pharmaceutical Co., Ltd. is a private company that manufactures biological pharmaceutical products. Changchun Baiyi Pharmaceutical Co., Ltd. is based in Changchun, China. Changchun Baiyi Pharmaceutical Co. was acquired by Changchun BCHT Biotechnology Co. on June 14, 2013 for $1.67 million. | Director/Board Member | 01-08-2013 |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Opleiding van Xiu Feng Li
| Jilin University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | Health Technology |
| CHANGCHUN BCHT BIOTECHNOLOGY CO. | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
Jilin Huakang Pharmaceutical Co. Ltd.
Jilin Huakang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High & New Technology Industries (Group), Inc., Jilin Huakang Pharmaceutical Co. Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Dunhua, China. | Health Technology |
GeneScience Pharmaceuticals Co., Ltd.
GeneScience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology GeneScience Pharmaceuticals Co., Ltd. engages in the production and sale of biopharmaceutical products. Its products include bioengineering products such as recombinant human growth hormones, active pharmaceutical ingredients such as tripplein acetate and alprostadil, freeze-dried powder injections, small volume injections, biological product intermediates, and medical devices. The company was founded by Lei Jin in 1996 and is headquartered in Changchun, China. | Health Technology |
| Changchun Chenguang Pharmaceutical Co. Ltd. | |
| Changchun BCHT Pharmaceuticals Co. Ltd. | |
| Jilin Maifeng Biological Pharmaceutical Co., Ltd. | |
| Qinhuangdao Shanhaiguan Pharmaceutical Co. Ltd. | |
Changchun Baiyi Pharmaceutical Co., Ltd.
Changchun Baiyi Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Baiyi Pharmaceutical Co., Ltd. is a private company that manufactures biological pharmaceutical products. Changchun Baiyi Pharmaceutical Co., Ltd. is based in Changchun, China. Changchun Baiyi Pharmaceutical Co. was acquired by Changchun BCHT Biotechnology Co. on June 14, 2013 for $1.67 million. | Health Technology |
Changchun Genescience Pharmaceuticals Co., Ltd.
 Changchun Genescience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Genescience Pharmaceuticals Co., Ltd. is a private company that manufactures pharmaceutical products. Changchun Genescience Pharmaceuticals Co., Ltd. is based in Changchun, China. The Chinese company was founded in 1997. The CEO is Lei Jin. | Health Technology |
